Columbia Laboratories, Inc. Amends Stockholder Rights Plan to Preserve Use of Net Operating Losses Under Section 382

LIVINGSTON, N.J.--(BUSINESS WIRE)--Columbia Laboratories, Inc. (Nasdaq: CBRX) today announced that its Board of Directors has amended its Stockholder Rights Plan (the “Rights Plan”), adopted March 12, 2002, to preserve the value of significant tax assets associated with the Company’s tax net operating loss carryforwards (“NOLs”) under Section 382 of the Internal Revenue Code.

MORE ON THIS TOPIC